The phospholipase A2 receptor (PLA2R) was recently discovered as a target autoantigen in
patients with idiopathic membranous nephropathy (IMN). Published evidence suggests that …

Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of
Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China - PMC Back …

The M-type receptor for phospholipase A2 (PLA2R1) is the major target antigen in idiopathic
membranous nephropathy (iMN). Our recent genome-wide association study showed that …

Aim The phospholipase A2 receptor (PLA2R) is the major target antigen in idiopathic
membranous nephropathy (iMN). The aim of this prospective study was to determine the …

The identification of circulating autoantibodies against the M-type phospholipase A₂
receptor (anti-PLA₂R) in patients with idiopathic membranous nephropathy (iMN) has been …

Background Glomerular M‐type phospholipase A2 receptor (PLA2R) is important for
diagnosing idiopathic membranous nephropathy (IMN). The relation between glomerular …

Autoantibodies to M-type phospholipase A2 receptor (PLA2R) are specific markers of
idiopathic membranous nephropathy (IMN). They can differentiate IMN from other …

Background: M-type phospholipase A 2 receptor (PLA 2 R) has been identified as the major
target antigen in idiopathic membranous nephropathy (IMN). However, the role of …

Results. Positive anti-PLA2R antibodies at diagnosis were found in 16 of 33 patients
(48.5%). Anti-PLA2R levels were independently associated with the achievement of …

Background Serum phospholipase A2 receptor (PLA2R) antibody (SAb) and glomerular
deposits of PLA2R antigen (GAg) have been tested widely in idiopathic membranous …